Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery

The adaptation of existing antimalarial nanocarriers to new Plasmodium stages, drugs, targeting molecules, or encapsulating structures is a strategy that can provide new nanotechnology-based, cost-efficient therapies against malaria. We have explored the modification of different liposome prototypes...

ver descrição completa

Detalhes bibliográficos
Autor principal: Marques, Joana (author)
Outros Autores: Valle-Delgado, Juan José (author), Urbán, Patricia (author), Baró, Elisabet (author), Prohens, Rafel (author), Mayor, Alfredo (author), Cisteró, Pau (author), Delves, Michael (author), Sinden, Robert E. (author), Grandfils, Christian (author), de Paz, José L. (author), García-Salcedo, José A. (author), Fernàndez-Busquets, Xavier (author)
Formato: article
Idioma:eng
Publicado em: 2018
Assuntos:
Glycosaminoglycans
Malaria
Nanomedicine
Plasmodium
Targeted drug delivery
Bioengineering
Medicine (miscellaneous)
Molecular Medicine
Biomedical Engineering
Materials Science(all)
Pharmaceutical Science
SDG 3 - Good Health and Well-being
Texto completo:https://doi.org/10.1016/j.nano.2016.09.010
País:Portugal
Oai:oai:run.unl.pt:10362/37824

Texto Completo

https://doi.org/10.1016/j.nano.2016.09.010

Registos relacionados